Discovering The Role of IGHV3-69-1 in Tissue Expression and Signaling Pathways

Target Name: IGHV3-69-1

NCBI ID: G28402

IGHV3-69-1

Discovering The Role of IGHV3-69-1 in Tissue Expression and Signaling Pathways

IGHV3-69-1 (IGHV3-11) is a glycoprotein that is expressed in most tissues of the body. It is a type of transmembrane protein that is characterized by the presence of a variable region and a constant region. The variable region of IGHV3-69-1 consists of a variable region that is composed of four constant amino acids, while the constant region consists of a variable number of amino acids.

IGHV3-69-1 is a protein that is expressed in most tissues of the body, including the brain, heart, kidneys, and intestines. It is also expressed in the placenta, which suggests that it may be involved in fetal development and growth.

One of the unique features of IGHV3-69-1 is its structure. It has a unique topology, with the variable region located at the extracellular side of the cell and the constant region located at the intracellular side. This is unusual, as most transmembrane proteins have the variable region located at the intracellular side and the constant region located at the extracellular side.

IGHV3-69-1 has also been shown to play a role in the immune response. It is a component of the major histocompatibility complex (MHC), which is a protein that is expressed in most tissues of the body and is involved in the immune response. IGHV3-69-1 is known as the major histocompatibility complex class I region D molecule, and it is one of the proteins that are expressed in the MHC.

In addition to its role in the immune response, IGHV3-69-1 has also been shown to play a role in the regulation of cell signaling pathways. It is a component of the T-cell receptor, which is a protein that is expressed in T cells and plays a role in cell signaling. IGHV3-69-1 is known as the T-cell receptor alpha chain, and it is one of the proteins that is expressed in the T-cell receptor.

IGHV3-69-1 has also been shown to be involved in the regulation of inflammation. It is a component of the nuclear factor kappa B (NFKB), which is a protein that is involved in inflammation. IGHV3-69-1 is known as the nuclear factor kappa B alpha chain, and it is one of the proteins that is expressed in the NFKB.

In conclusion, IGHV3-69-1 is a glycoprotein that is expressed in most tissues of the body. It is characterized by the presence of a variable region and a constant region, and it has unique topology. IGHV3-69-1 is involved in the immune response, cell signaling pathways, and inflammation. As a result, it may be a drug target or biomarker for future scientific studies.

Protein Name: Immunoglobulin Heavy Variable 3-69-1 (pseudogene)

The "IGHV3-69-1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGHV3-69-1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets